Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Minority Interest (2018 - 2025)

PAVmed has reported Minority Interest over the past 6 years, most recently at -$11.7 million for Q4 2025.

  • For Q4 2025, Minority Interest fell 157.1% year-over-year to -$11.7 million; the TTM value through Dec 2025 reached -$11.7 million, down 157.1%, while the annual FY2025 figure was -$11.7 million, 157.1% down from the prior year.
  • Minority Interest for Q4 2025 was -$11.7 million at PAVmed, down from -$10.0 million in the prior quarter.
  • Over five years, Minority Interest peaked at $56.3 million in Q3 2024 and troughed at -$11.7 million in Q4 2025.
  • A 5-year average of $16.6 million and a median of $19.1 million in 2022 define the central range for Minority Interest.
  • Biggest five-year swings in Minority Interest: surged 5286.81% in 2022 and later crashed 157.1% in 2025.
  • Year by year, Minority Interest stood at $17.8 million in 2021, then increased by 16.13% to $20.6 million in 2022, then surged by 44.62% to $29.8 million in 2023, then crashed by 115.22% to -$4.5 million in 2024, then crashed by 157.1% to -$11.7 million in 2025.
  • Business Quant data shows Minority Interest for PAVM at -$11.7 million in Q4 2025, -$10.0 million in Q3 2025, and -$9.4 million in Q2 2025.